Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2019

Nov 22, 2019

30071_dirs_2019-11-22_cc536ad3-a0c7-432f-b98e-31394092434a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-21

Reporting Person: Sodhi Rajwant (President, SaaS Business)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-21 ResMed Common Stock A 23594 $146.34 Acquired 54381 Direct
2019-11-21 ResMed Common Stock F 13161 $146.34 Disposed 41220 Direct

Footnotes

F1: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on November 21, 2019, when the compensation committee certified that the performance metrics were met.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.